바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기



Physician Directory

HOME > Hospitals > Severance Hospital > Departments > Gastroenterology > Physician Directory

Information of doctor

Go list

Heeseung Lee
doctor's information
Name Heeseung Lee
Department
Major
Homepage
Blog

Research

Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigens
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 29/4 :843-850,2014

유두부 종양의 진단과 치료에서 내시경의 역할
The Korean Journal of Pancreas and Biliary Tract 19/3 :121-127,2014

Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer
CHEMOTHERAPY 61/3 :152-158,2016

Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existingdiabetes existingdiabetes mellitus type 2
DIGESTIVE AND LIVER DISEASE 48/4 :435-440,2016

Statin Use and Its Impact on Survival in Pancreatic Cancer Patients Cancer Patients
MEDICINE 95/19 :e3607-,2016

Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses
PLOS ONE 11/5 :e0154401-,2016

Incidence and risk factors of delayed postpolypectomy bleeding in patients with chronic liver disease
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 51/5 :618-624,2016

Systemic Chemotherapy in Advanced Pancreatic Cancer
GUT AND LIVER 10/3 :340-347,2016

Past, Present, and Future of Gastrointestinal Stents: New Endoscopic Ultrasonography- Guided Metal Stents and Future Developments
Clinical Endoscopy 49/2 :131-138,2016

A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea.
MEDICINE 96/1 :e5702-,2017

A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
SCIENTIFIC REPORTS 7/41615 :1-9,2017

The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer.
JOURNAL OF MOLECULAR RECOGNITION 30/4 :e2591-,2017

Clinical characteristics of second primary pancreatic cancer
PLOS ONE 12/6 :e0179784-,2017

Benefit of neoadjuvant concurrent chemoradiotherapy locally advanced perihilar cholangiocarcinoma
WORLD JOURNAL OF GASTROENTEROLOGY 23/18 :3,301-3,308,2017

The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL 69/3 :512-519,2017

Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer
CHEMOTHERAPY 62/6 :361-366,2017

Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer “in a Korean” population: A single-center cohort study
SEMINARS IN ONCOLOGY 44/ :420-427,2017

Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis
PLOS ONE 13/2 :e0190835-,2018

Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer
SCIENTIFIC REPORTS 8/1 :3,383-3,389,2018

Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer.
GASTROINTESTINAL ENDOSCOPY 87/3 :688-694,2018

Revision of bilateral self-expandable metallic stents placed using the stent-in-stent technique for malignant hilar biliary obstruction.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL 17/5 :437-442,2018

Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
World Journal of Gastrointestinal Oncology 10/11 :421-430,2018

Clinical Outcomes of Bilateral Stent-in-Stent Placement Using Self-Expandable Metallic Stent for High-Grade Malignant Hilar Biliary Obstruction
YONSEI MEDICAL JOURNAL 59/7 :827-833,2018

Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20/3 :-,2019

KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL 18/1 :62-66,2019

콘텐츠 처음으로 이동